SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-251517
Filing Date
2018-08-17
Accepted
2018-08-17 14:11:58
Documents
4
Period of Report
2018-08-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d424208d8k.htm 8-K 20717
2 EX-99.1 d424208dex991.htm EX-99.1 135222
3 EX-99.2 d424208dex992.htm EX-99.2 6597
4 GRAPHIC g424208g0817073633486.jpg GRAPHIC 3424
  Complete submission text file 0001193125-18-251517.txt   168633
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 181025487
SIC: 2836 Biological Products, (No Diagnostic Substances)